 ACTON, Mass.--BUSINESS WIRE--Insulet Corporation NASDAQ: PODD Insulet or the Company, the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced its schedule of events for the American Diabetes Association ADA Virtual 81st Scientific Sessions June 25 29, 2021. Following the release of its initial pivotal trial results in March, Insulet will present new clinical outcomes data for preschool children with type 1 diabetes using the Omnipod 5 